Skip to main content
The Markets by Proactive
Go to Proactive Australia

Archive

Psyched Wellness shares key milestone in Maximum Tolerated Dosage study of Amanita Muscaria extract

Psyched Wellness shares key milestone in Maximum Tolerated Dosage study of Amanita Muscaria extract

Psyched Wellness Ltd (CSE:PSYC) (OTCQB:PSYCF) CEO Jeffrey Stevens tells Proactive the life sciences company revealed the results from its Maximum Tolerated Dosage (MTD) study of AME-1 conducted by KGK Science.

Stevens says this key milestones gives the group the MTD safe for consumption. Now, the group will move into a 14-day and then a 90-day oral toxicity study.